Oct 22, 2024 / 07:00AM GMT
Sveinn Sölvason - Embla Medical hf - President and Chief Executive Officer
Good morning, and welcome to the Embla Medical conference call where we will review the third quarter results for 2024. I'm [Sveinn] Solvason, CEO of Embla Medical and joining the joining me today here from Copenhagen is our Chief Financial Officer, Arna Sveinsdottir and Embla Medical's Head of Investor Relations, Klaus Sindahl.
Today we'll discuss the financial performance and progress we've made during the third quarter. The presentation should take roughly 15 minutes after which there will be an opportunity to ask questions during a Q&A session.
If you go to the next slide please, we continue to deliver solid growth. Organic sales growth was 7% and local currency growth was 11% including an impact from M&A and currency. We continue to see a strong momentum in the EMEA driven by prosthetics and neuro products as well as patient care. Our pricing and support business, however, delivered a more modest growth for the quarter.
Our EBITDA margin came in strong at 22% supported by
Q3 2024 Embla Medical hf Earnings Call Transcript
Oct 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers